questionsmedicales.fr
Phénomènes microbiologiques
Phénomènes physiologiques viraux
Interférence virale
Interférence virale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Polymorphism, Single Nucleotide
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Interférence virale : Questions médicales les plus fréquentes",
"headline": "Interférence virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Interférence virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-15",
"dateModified": "2025-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Interférence virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénomènes physiologiques viraux",
"url": "https://questionsmedicales.fr/mesh/D018406",
"about": {
"@type": "MedicalCondition",
"name": "Phénomènes physiologiques viraux",
"code": {
"@type": "MedicalCode",
"code": "D018406",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G06.920"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Interférence virale",
"alternateName": "Viral Interference",
"code": {
"@type": "MedicalCode",
"code": "D014762",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jocelyne Piret",
"url": "https://questionsmedicales.fr/author/Jocelyne%20Piret",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Guy Boivin",
"url": "https://questionsmedicales.fr/author/Guy%20Boivin",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Shou-Wei Ding",
"url": "https://questionsmedicales.fr/author/Shou-Wei%20Ding",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Plant Pathology, University of California, Riverside, Riverside, CA, USA. Electronic address: shou-wei.ding@ucr.edu."
}
},
{
"@type": "Person",
"name": "Ke Li",
"url": "https://questionsmedicales.fr/author/Ke%20Li",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Daniel M Weinberger",
"url": "https://questionsmedicales.fr/author/Daniel%20M%20Weinberger",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Novel single nucleotide polymorphisms in gestational diabetes mellitus.",
"datePublished": "2022-11-12",
"url": "https://questionsmedicales.fr/article/36375523",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cca.2022.11.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36847373",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3791/64361"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association between single nucleotide polymorphisms in exon 3 of the",
"datePublished": "2022-11-15",
"url": "https://questionsmedicales.fr/article/36380611",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13816810.2022.2092757"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin.",
"datePublished": "2022-09-05",
"url": "https://questionsmedicales.fr/article/36065506",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/17512433.2022.2118714"
}
},
{
"@type": "ScholarlyArticle",
"name": "Potential role of FKBP5 single-nucleotide polymorphisms in functional seizures.",
"datePublished": "2023-03-21",
"url": "https://questionsmedicales.fr/article/36825897",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/epi4.12716"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008827"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques viraux",
"item": "https://questionsmedicales.fr/mesh/D018406"
},
{
"@type": "ListItem",
"position": 4,
"name": "Interférence virale",
"item": "https://questionsmedicales.fr/mesh/D014762"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Interférence virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Interférence virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Interférence virale",
"description": "Comment diagnostiquer l'interférence virale ?\nQuels tests sont utilisés pour l'interférence virale ?\nL'interférence virale peut-elle être détectée cliniquement ?\nQuels marqueurs biologiques indiquent l'interférence ?\nPeut-on utiliser des modèles animaux pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014762?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Interférence virale",
"description": "Quels sont les symptômes de l'interférence virale ?\nL'interférence virale provoque-t-elle des symptômes spécifiques ?\nComment l'interférence affecte-t-elle les symptômes ?\nLes symptômes varient-ils selon le virus ?\nL'interférence virale peut-elle masquer des symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D014762?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Interférence virale",
"description": "Comment prévenir l'interférence virale ?\nLes mesures d'hygiène aident-elles à prévenir l'interférence ?\nLes campagnes de vaccination sont-elles efficaces ?\nFaut-il éviter les contacts avec des personnes malades ?\nLes traitements préventifs sont-ils disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D014762?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Interférence virale",
"description": "Quels traitements sont efficaces contre l'interférence virale ?\nLes antiviraux aident-ils en cas d'interférence ?\nPeut-on utiliser des vaccins pour prévenir l'interférence ?\nComment gérer les complications liées à l'interférence ?\nLes traitements immunomodulateurs sont-ils efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D014762?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Interférence virale",
"description": "Quelles complications peuvent survenir avec l'interférence virale ?\nL'interférence virale peut-elle aggraver des maladies existantes ?\nComment surveiller les complications potentielles ?\nLes complications sont-elles prévisibles ?\nQuels facteurs augmentent le risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D014762?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Interférence virale",
"description": "Quels sont les principaux facteurs de risque d'interférence virale ?\nL'environnement joue-t-il un rôle dans l'interférence ?\nLes antécédents médicaux influencent-ils le risque ?\nLe mode de vie affecte-t-il le risque d'interférence ?\nLes voyages augmentent-ils le risque d'interférence virale ?",
"url": "https://questionsmedicales.fr/mesh/D014762?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'interférence virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests virologiques et l'observation des interactions virales."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'interférence virale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests PCR et des cultures cellulaires sont souvent utilisés pour détecter l'interférence."
}
},
{
"@type": "Question",
"name": "L'interférence virale peut-elle être détectée cliniquement ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes atypiques peuvent indiquer une interférence virale lors d'infections."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques indiquent l'interférence ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux d'anticorps ou de cytokines peuvent signaler une interférence virale."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des modèles animaux pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des modèles animaux sont souvent utilisés pour étudier l'interférence virale."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'interférence virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure fièvre, fatigue, et manifestations respiratoires."
}
},
{
"@type": "Question",
"name": "L'interférence virale provoque-t-elle des symptômes spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes sont souvent non spécifiques et varient selon les virus impliqués."
}
},
{
"@type": "Question",
"name": "Comment l'interférence affecte-t-elle les symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut atténuer ou aggraver les symptômes d'une infection virale coexistante."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent des virus en interaction et de l'état immunitaire de l'hôte."
}
},
{
"@type": "Question",
"name": "L'interférence virale peut-elle masquer des symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut masquer des symptômes d'autres infections virales, rendant le diagnostic difficile."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'interférence virale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination et l'hygiène personnelle sont essentielles pour réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène aident-elles à prévenir l'interférence ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mesures d'hygiène rigoureuses peuvent réduire la transmission des virus."
}
},
{
"@type": "Question",
"name": "Les campagnes de vaccination sont-elles efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles réduisent l'incidence des infections virales et donc le risque d'interférence."
}
},
{
"@type": "Question",
"name": "Faut-il éviter les contacts avec des personnes malades ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les contacts avec des personnes infectées peut réduire le risque d'interférence."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs sont-ils disponibles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements préventifs existent, mais leur utilisation dépend des virus en circulation."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre l'interférence virale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique; la gestion des symptômes est essentielle."
}
},
{
"@type": "Question",
"name": "Les antiviraux aident-ils en cas d'interférence ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux peuvent être utiles, mais leur efficacité dépend des virus impliqués."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des vaccins pour prévenir l'interférence ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vaccins peuvent réduire le risque d'infection, mais ne préviennent pas toujours l'interférence."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à l'interférence ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite une approche symptomatique et un suivi médical."
}
},
{
"@type": "Question",
"name": "Les traitements immunomodulateurs sont-ils efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent aider à réguler la réponse immunitaire, mais leur efficacité varie selon les cas."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'interférence virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications respiratoires et neurologiques peuvent survenir en cas d'interférence."
}
},
{
"@type": "Question",
"name": "L'interférence virale peut-elle aggraver des maladies existantes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut exacerber des maladies chroniques comme l'asthme ou la BPCO."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications potentielles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier est crucial pour détecter et gérer les complications."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles, surtout chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies sous-jacentes et l'immunodépression augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'interférence virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, l'âge avancé et les infections coexistantes."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle dans l'interférence ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des environnements surpeuplés ou insalubres augmentent le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou virales augmentent le risque d'interférence."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque d'interférence ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'interférence virale ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages dans des zones à forte incidence virale peuvent accroître le risque d'infection."
}
}
]
}
]
}
The association between gestational diabetes mellitus (GDM) and single nucleotide polymorphisms (SNPs) has attracted global research attention. Exploring SNPs can help us further understand the pathog...
Mutations in the mitochondrial genome (mtDNA) have been associated with maternally inherited genetic diseases. However, interest in mtDNA polymorphisms has increased in recent years due to the recentl...
The mutations in the αA-crystallin (CRYAA) gene may contribute to the development of age-related cataract (ARC). In this study, we searched for single nucleotide polymorphisms (SNP) in exons of CRYAA ...
Peripheral venous blood was collected for the extraction of genomic DNA. Three exons of CRYAA were sequenced to detect SNPs. The frequency distributions of alleles and genotypes were compared between ...
There were 618 patients with various subtypes of ARC (nuclear cataract [NC], cortical cataract [CC], posterior subcapsular cataract [PSC]). The control group comprised 236 patients. The incidence of e...
The SNP rs76740365 G>A in exon 3 of the CRYAA gene is associated with greater susceptibility of ARC, particularly the PSC subtype. Individuals carrying the SNP rs76740365 G>A may be more likely to dev...
Metformin has been recognized as the first-choice drug for type 2 diabetes mellitus (T2DM). The potency of metformin in the treatment of type 2 diabetes has always been in the spotlight and shown sign...
Here, we reviewed the current knowledge about gene polymorphisms impacting metformin efficacy based on transporter and drug target proteins....
The reason for the difference in clinical drug potency of metformin can be attributed to the gene polymorphism of drug transporters and drug target proteins in the human body. Substantial evidence sho...
We investigated the associations between FKBP5 single-nucleotide polymorphisms (SNPs) and functional seizures (FS)....
Seventy patients with FS, 140 with major depressive disorder (MDD), and 140 healthy controls were studied. Their DNAs were analyzed for the rs1360780 in the 3' region and rs9470080 in the 5' region of...
Patients with FS and those with MDD had less GG and more AA genotypes in both rs9470080 and rs1360780 SNPs compared with those in healthy controls. Similar results were observed for allelic frequencie...
Patients with FS and those with MDD had significantly different genotypes in both rs9470080 and rs1360780 SNPs compared with those in healthy controls. However, it seems that FKBP5 polymorphisms were ...
The susceptibility of different individuals to anesthetics varies widely, and sevoflurane is no exception. We hypothesized that polymorphisms in genes involved in pharmacokinetics and pharmacodynamics...
Genome-wide copy number profiling by single-nucleotide polymorphism (SNP) array is increasingly employed in the clinical diagnostic workup of melanocytic tumors. We present our SNP array results on 67...
Systematic research on the associations between vital single nucleotide polymorphisms (SNPs) in MALAT1 and cancer risk was still lacking. Thus, we performed this study....
The literature searches were until April 1, 2022. The pooled association-analysis results were assessed by odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) in three genetic model...
Eighteen articles about four SNPs (rs619586, rs664589, rs1194338, and rs3200401) involving 11,843 cancer cases and 14,682 controls were collected. Rs619586, rs664589, and rs1194338 were associated wit...
The functional SNPs in MALAT1 correlated with cancer risk. MALAT1 and its vital functional SNPs might be potential biomarkers for predicting the risk and prognosis of two types of cancer, especially C...
Single-nucleotide polymorphisms in G protein subunits are linked to an increased risk of cardiovascular events among the general population. We assessed the effects of...
Gender incongruence (GI) is characterized by a marked incongruence between an individual's experienced/expressed gender and the assigned sex at birth. It includes strong displeasure about his or her s...
We analyzed 74 single nucleotide polymorphisms located at the metabotropic glutamate receptors (mGluR1, mGluR3, mGluR4, mGluR5, mGluR7 and mGluR8) in 94 transgender...
After analysis of allele and genotypic frequencies, we found twenty-five polymorphisms with significant differences at level P ≤ 0.05, five at P ≤ 0.005 and two at P ≤ 0.0005. Furthermore, the only tw...
We provide genetic evidence that the mGluR7, and therefore glutamatergic neurotransmission, may be involved in GI and GD....